These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24072591)

  • 21. [Myostatin blockade therapy for muscular atrophy].
    Sunada Y
    Brain Nerve; 2011 Nov; 63(11):1271-7. PubMed ID: 22068480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues.
    Dong J; Dong Y; Dong Y; Chen F; Mitch WE; Zhang L
    Int J Obes (Lond); 2016 Mar; 40(3):434-442. PubMed ID: 26435323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiting myostatin signaling prevents femoral trabecular bone loss and microarchitecture deterioration in diet-induced obese rats.
    Tang L; Yang X; Gao X; Du H; Han Y; Zhang D; Wang Z; Sun L
    Exp Biol Med (Maywood); 2016 Feb; 241(3):308-16. PubMed ID: 26438721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Building muscle, browning fat and preventing obesity by inhibiting myostatin.
    Lebrasseur NK
    Diabetologia; 2012 Jan; 55(1):13-7. PubMed ID: 22057197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.
    Dankbar B; Fennen M; Brunert D; Hayer S; Frank S; Wehmeyer C; Beckmann D; Paruzel P; Bertrand J; Redlich K; Koers-Wunrau C; Stratis A; Korb-Pap A; Pap T
    Nat Med; 2015 Sep; 21(9):1085-90. PubMed ID: 26236992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minireview: The link between fat and bone: does mass beget mass?
    Zaidi M; Buettner C; Sun L; Iqbal J
    Endocrinology; 2012 May; 153(5):2070-5. PubMed ID: 22467495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.
    Bauer JM; Cruz-Jentoft AJ; Fielding RA; Kanis JA; Reginster JY; Bruyère O; Cesari M; Chapurlat R; Al-Daghri N; Dennison E; Kaufman JM; Landi F; Laslop A; Locquet M; Maggi S; McCloskey E; Perna S; Rizzoli R; Rolland Y; Rondanelli M; Szulc P; Vellas B; Vlaskovska M; Cooper C
    Calcif Tissue Int; 2019 Aug; 105(2):109-124. PubMed ID: 31098729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of sarcopenia with and without fracture.
    Tarantino U; Baldi J; Scimeca M; Piccirilli E; Piccioli A; Bonanno E; Gasbarra E
    Injury; 2016 Oct; 47 Suppl 4():S3-S10. PubMed ID: 27496721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caveolin-3 regulates myostatin signaling. Mini-review.
    Ohsawa Y; Okada T; Kuga A; Hayashi S; Murakami T; Tsuchida K; Noji S; Sunada Y
    Acta Myol; 2008 Jul; 27(1):19-24. PubMed ID: 19108573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels.
    Ilich JZ; Kelly OJ; Inglis JE; Panton LB; Duque G; Ormsbee MJ
    Ageing Res Rev; 2014 May; 15():51-60. PubMed ID: 24632496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide-2 from mouse myostatin precursor protein alleviates muscle wasting in cancer-associated cachexia.
    Ojima C; Noguchi Y; Miyamoto T; Saito Y; Orihashi H; Yoshimatsu Y; Watabe T; Takayama K; Hayashi Y; Itoh F
    Cancer Sci; 2020 Aug; 111(8):2954-2964. PubMed ID: 32519375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral content and density in the humerus of adult myostatin-deficient mice.
    Hamrick MW; McPherron AC; Lovejoy CO
    Calcif Tissue Int; 2002 Jul; 71(1):63-8. PubMed ID: 12060865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.
    Souza TA; Chen X; Guo Y; Sava P; Zhang J; Hill JJ; Yaworsky PJ; Qiu Y
    Mol Endocrinol; 2008 Dec; 22(12):2689-702. PubMed ID: 18927237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Findings as a starting point to unravel the underlying mechanisms of in vivo interactions involving Wnt10a in bone, fat and muscle.
    Tsukamoto M; Wang KY; Tasaki T; Murata Y; Okada Y; Yamanaka Y; Nakamura E; Yamada S; Izumi H; Zhou Q; Azuma K; Sasaguri Y; Kohno K; Sakai A
    Bone; 2019 Mar; 120():75-84. PubMed ID: 30315998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The central role of myostatin in skeletal muscle and whole body homeostasis.
    Elliott B; Renshaw D; Getting S; Mackenzie R
    Acta Physiol (Oxf); 2012 Jul; 205(3):324-40. PubMed ID: 22340904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High dose dietary vitamin D allocates surplus calories to muscle and growth instead of fat via modulation of myostatin and leptin signaling.
    Roizen J; Long C; Casella A; Nguyen M; Danahy L; Seiler C; Lei M; Mark J
    Res Sq; 2024 May; ():. PubMed ID: 38766160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.
    Avin KG; Moorthi RN
    Curr Osteoporos Rep; 2015 Jun; 13(3):173-9. PubMed ID: 25691218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation.
    Adhikary S; Choudhary D; Tripathi AK; Karvande A; Ahmad N; Kothari P; Trivedi R
    Life Sci; 2019 Jul; 229():261-276. PubMed ID: 31082400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
    Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
    Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.